Log In
Print
BCIQ
Print
Print this Print this
 

Fastic, Starlix, Starsis, nateglinide (YM026)

Also known as: A-4166

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionD-phenylalanine amino acid derivative
Molecular Target ATP-dependent potassium channel (KATP)
Mechanism of ActionATP-dependent potassium channel (KATP) blocker
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsPrevent Type II diabetes; Treat Type II diabetes; Treat Type II diabetes in combination with thiazolidinedione
Regulatory Designation

Partner

Ajinomoto Co. Inc.; Astellas Pharma Inc.; Daiichi Sankyo Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today